Immunohistochemistry (IHC) Market, by Product (Antibodies (Primary Antibodies and Secondary Antibodies), Equipment (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, and Others), Reagents (Histological Stains, Blocking

Immunohistochemistry (IHC) Market, by Product (Antibodies (Primary Antibodies and Secondary Antibodies), Equipment (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, and Others), Reagents (Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, and Others), and Kits), by Application (Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, and Others), Drug Testing, and Forensic Applications), by End User (Hospitals, Diagnostic Laboratories, Research Institutes, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Immunohistochemistry (IHC) is an experimental method that uses antibodies to locate specific antigens (markers) in tissue samples. Antibodies usually bind to enzymes or fluorescent dye. After the antibody binds to the antigen in the tissue sample, the enzyme or dye is activated and then the antigen can be observed under a microscope. Immunohistochemistry is useful in diagnosing diseases such as cancer, infectious diseases, and cardiovascular diseases (CVDs), and others. It can also be used to distinguish between different types of cancer.
IHC as a crucial application of monoclonal and polyclonal antibodies, helps understand tissue distribution of an antigen. It is used in the identification of enzymes, tumor suppressor genes, antigens, and tumor cell proliferation. IHC involves specific antigen-antibody reactions compared to traditional enzyme staining techniques that identify a limited number of proteins, enzymes, and tissue structures. As a result, visualizing the distribution and location of specific cellular components within cells is becoming increasingly important as an important technique in medical laboratories and clinical diagnostics.
Market Dynamics
Increasing prevalence of chronic diseases such as cancer is anticipated to drive the growth of global immunohistochemistry (IHC) market over the forecast period. For instance, according to the National Institutes of Health (NIH), in 2018, an estimated 1,735,350 new cases of cancer were detected in the U.S. Moreover, according to data published by World Health Organization (WHO) in 2018, globally, cancer was one of the leading causes of mortality, and in 2018 approximately 9.6 million deaths were registered globally due to cancer.
Key features of the study:
This report provides in-depth analysis of the global immunohistochemistry (IHC) market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global immunohistochemistry (IHC) market based on the following parameters – company highlights, Products portfolio, key highlights, financial performance, and market strategies
Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Danaher Corporation, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB, Agilent Technologies, Inc., Abcam plc., Becton, Dickinson and Company, Takara Bio, Inc., Eagle Biosciences, Inc., Biocare Medical, LLC, Biogenex Laboratories, Diagnostic Biosystems, Inc., and BioVision Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, Product up-gradation, market expansion, and marketing tactics
The global immunohistochemistry (IHC) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunohistochemistry (IHC) market
Detailed Segmentation:
Global Immunohistochemistry (IHC) Market, By Product:
Antibodies
Primary Antibodies
Secondary Antibodies
Equipment
Slide Staining Systems
Tissue Microarrays
Tissue Processing Systems
Slide Scanners
Others
Reagents
Histological Stains
Blocking Sera and Reagents
Chromogenic Substrates
Fixation Reagents
Stabilizers
Others
Kits
Global Immunohistochemistry (IHC) Market, By Application:
Diagnostics
Cancer
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Diabetes Mellitus
Others
Drug Testing
Forensic Applications
Global Immunohistochemistry (IHC) Market, By End User:
Hospitals
Diagnostic Laboratories
Research Institutes
Others
Global Immunohistochemistry (IHC) Market, By Region:
North America
By Product
Antibodies
Primary Antibodies
Secondary Antibodies
Equipment
Slide Staining Systems
Tissue Microarrays
Tissue Processing Systems
Slide Scanners
Others
Reagents
Histological Stains
Blocking Sera and Reagents
Chromogenic Substrates
Fixation Reagents
Stabilizers
Others
Kits
By Application
Diagnostics
Cancer
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Diabetes Mellitus
Others
Drug Testing
Forensic Applications
By End User
Hospitals
Diagnostic Laboratories
Research Institutes
Others
By Country
U.S.
Canada
Latin America
By Product
Antibodies
Primary Antibodies
Secondary Antibodies
Equipment
Slide Staining Systems
Tissue Microarrays
Tissue Processing Systems
Slide Scanners
Others
Reagents
Histological Stains
Blocking Sera and Reagents
Chromogenic Substrates
Fixation Reagents
Stabilizers
Others
Kits
By Application
Diagnostics
Cancer
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Diabetes Mellitus
Others
Drug Testing
Forensic Applications
By End User
Hospitals
Diagnostic Laboratories
Research Institutes
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product
Antibodies
Primary Antibodies
Secondary Antibodies
Equipment
Slide Staining Systems
Tissue Microarrays
Tissue Processing Systems
Slide Scanners
Others
Reagents
Histological Stains
Blocking Sera and Reagents
Chromogenic Substrates
Fixation Reagents
Stabilizers
Others
Kits
By Application
Diagnostics
Cancer
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Diabetes Mellitus
Others
Drug Testing
Forensic Applications
By End User
Hospitals
Diagnostic Laboratories
Research Institutes
Others
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product
Antibodies
Primary Antibodies
Secondary Antibodies
Equipment
Slide Staining Systems
Tissue Microarrays
Tissue Processing Systems
Slide Scanners
Others
Reagents
Histological Stains
Blocking Sera and Reagents
Chromogenic Substrates
Fixation Reagents
Stabilizers
Others
Kits
By Application
Diagnostics
Cancer
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Diabetes Mellitus
Others
Drug Testing
Forensic Applications
By End User
Hospitals
Diagnostic Laboratories
Research Institutes
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product
Antibodies
Primary Antibodies
Secondary Antibodies
Equipment
Slide Staining Systems
Tissue Microarrays
Tissue Processing Systems
Slide Scanners
Others
Reagents
Histological Stains
Blocking Sera and Reagents
Chromogenic Substrates
Fixation Reagents
Stabilizers
Others
Kits
By Application
Diagnostics
Cancer
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Diabetes Mellitus
Others
Drug Testing
Forensic Applications
By End User
Hospitals
Diagnostic Laboratories
Research Institutes
Others
By Country
GCC
Israel
Rest of Middle East
Africa
By Product
Antibodies
Primary Antibodies
Secondary Antibodies
Equipment
Slide Staining Systems
Tissue Microarrays
Tissue Processing Systems
Slide Scanners
Others
Reagents
Histological Stains
Blocking Sera and Reagents
Chromogenic Substrates
Fixation Reagents
Stabilizers
Others
Kits
By Application
Diagnostics
Cancer
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Diabetes Mellitus
Others
Drug Testing
Forensic Applications
By End User
Hospitals
Diagnostic Laboratories
Research Institutes
Others
By Region/Country
South Africa
Central Africa
North Africa
Company Profiles
Thermo Fisher Scientific, Inc.
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
F. Hoffmann-La Roche Ltd.
Merck KGaA
Danaher Corporation
Perkinelmer, Inc.
Bio-Rad Laboratories, Inc.
Cell Signaling Technology, Inc.
Bio SB
Agilent Technologies, Inc.
Abcam plc.
Becton, Dickinson and Company
Takara Bio, Inc.
Eagle Biosciences, Inc.
Biocare Medical, LLC
Biogenex Laboratories
Diagnostic Biosystems, Inc.
BioVision Inc.
“*” marked represents similar segmentation in other categories in the respective section.